Minerva Surgical Investor Relations Material
Latest events
Q2 2023
Minerva Surgical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Minerva Surgical Inc
Access all reports
Minerva Surgical Inc. is a medical device company focused on developing minimally invasive solutions for the treatment of abnormal uterine bleeding (AUB). The company's flagship product, the Minerva Endometrial Ablation System, is designed to treat AUB by removing the endometrial lining of the uterus. Minerva’s products aim to provide effective, less invasive alternatives to hysterectomy, improving outcomes for women suffering from AUB. The company is headquartered in Santa Clara, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
UTRS
Country
🇺🇸 United States